MyAverix Finance
US · Healthcare
Shanghai Fosun Pharmaceutical (Group) Co. Ltd (SFOSF)
Drug Manufacturers - Specialty & Generic
Shanghai Fosun Pharmaceutical (Group) Co. Ltd (SFOSF) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-30, reported market cap is $10.16B, P/E ratio is 15.00, net margin is 8.1%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for SFOSF
Shanghai Fosun Pharmaceutical (Group) Co. Ltd (SFOSF) — FAQ
What is Shanghai Fosun Pharmaceutical (Group) Co. Ltd's market cap?
Shanghai Fosun Pharmaceutical (Group) Co. Ltd (SFOSF) has a reported market cap of $10.16B (data as of 2026-03-30).
What is SFOSF's P/E ratio?
The price-to-earnings (P/E) ratio for Shanghai Fosun Pharmaceutical (Group) Co. Ltd (SFOSF) is 15.00 (data as of 2026-03-30).
Does Shanghai Fosun Pharmaceutical (Group) Co. Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Shanghai Fosun Pharmaceutical (Group) Co. Ltd (SFOSF). Check the MyAverix Finance app for the latest dividend data.
What sector is Shanghai Fosun Pharmaceutical (Group) Co. Ltd in?
Shanghai Fosun Pharmaceutical (Group) Co. Ltd (SFOSF) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is SFOSF listed on?
SFOSF is listed on US.
What is Shanghai Fosun Pharmaceutical (Group) Co. Ltd's net margin?
Shanghai Fosun Pharmaceutical (Group) Co. Ltd (SFOSF) reports a net margin of 8.1% (data as of 2026-03-30).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.